Transcranial Direct Current Stimulation

Transcranial Direct Stimulation (TDCS) is a form of non-invasive brain stimulation that uses low levels of electrical current to modulate brain activity. tDCS has shown promise for aphasia and apraxia of speech following stroke. By targeting specific areas of the brain involved in speech, tDCS aims to make the brain more receptive to speech treatment. tDCS is considered a non-risk device by the FDA and is safe to use.

Burke is accepting candidates for a clinical trial. Qualifying participant who have had a stroke and have apraxia of speech will receive 24 speech treatment sessions combined with tDCS at no charge. The duration of this trial, including follow-up assessments, may cover a 4-6 month period.

Who can participate:

• Individuals with aphasia/apraxia
• English is primary language
• Difficulty producing speech

Study Information: 

• NIH funded study
• Experimental treatment of speech impairments (24 sessions)
• 4-6 months total
• Experimental treatment includes low-intensity brain stimulation